Company news
Bausch + Lomb Corporation (NYSE:BLCO) news
Every Bausch + Lomb Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
September 1, 2026
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
August 24, 2026
Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
July 29, 2026
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
July 16, 2026
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 9, 2026
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
July 9, 2026
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
July 6, 2026
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
June 1, 2026
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 21, 2026
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
May 20, 2026
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
May 19, 2026
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe
May 7, 2026
Bausch + Lomb Announces Second R&D "Teach-in" Webinar
May 6, 2026
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
April 30, 2026
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
April 29, 2026
Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degener...
April 23, 2026
Bausch + Lomb Releases 2025 Sustainability Impact Report
April 22, 2026
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE R...
April 16, 2026
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
April 8, 2026
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
April 7, 2026
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
April 6, 2026
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
March 30, 2026
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
March 23, 2026
Bausch + Lomb Launches R&D "Teach-in" Webinar Series
March 9, 2026
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
February 24, 2026
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
February 18, 2026
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
February 17, 2026
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
January 20, 2026
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness...
January 5, 2026
Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
January 2, 2026
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025
Bausch + Lomb Announces Two Board of Directors Appointments
December 17, 2025
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
December 12, 2025
Bausch + Lomb to Participate in Citi Global Healthcare Conference
November 18, 2025
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day
November 13, 2025
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling ...
November 10, 2025
Bausch + Lomb to Hold Investor Day on Nov. 13
November 3, 2025
Bausch + Lomb Announces Third-Quarter 2025 Results
October 29, 2025
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
September 29, 2025
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
September 11, 2025
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symp...
September 9, 2025
Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States
September 8, 2025
Bausch + Lomb Announces Board Changes
August 18, 2025
Bausch + Lomb to Participate in Upcoming Investor Conferences
August 14, 2025
Bausch + Lomb Announces Second-Quarter 2025 Results
July 30, 2025
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
July 29, 2025
Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye
July 1, 2025
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
June 30, 2025
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including...
June 26, 2025
Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering
June 18, 2025